PFE - Pfizer Inc | StockAlert.pro

Stock Details

Pfizer Inc (PFE), a prominent company in the life sciences sector within the pharmaceutical preparations industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $24.88. Over the past 52 weeks, it has ranged between $20.18 and $28.43. This places the current price at 87.5% of its 52-week high and 23.3% above its 52-week low. Recent trading volume was recorded at 34,537,641. The International Securities Identification Number (ISIN) for this stock is US7170811035. There is currently 1 active alert set for PFE by users.

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

13.10

Below market average

Forward P/E

8.12

Earnings expected to grow

PEG Ratio

0.84

Potentially undervalued

Price to Book

1.59

EV/EBITDA

9.35

EPS (TTM)

$1.89

Price to Sales

2.21

Beta

0.44

Less volatile than market

How is PFE valued relative to its earnings and growth?

Pfizer Inc trades at a P/E ratio of 13.10, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of 8.12 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 0.84 suggests the stock may be undervalued relative to its growth rate.

What is PFE's risk profile compared to the market?

With a beta of 0.44, Pfizer Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.59 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

16.80%

Operating Margin

28.70%

Return on Equity

12.20%

Return on Assets

5.25%

Revenue Growth (YoY)

10.30%

Earnings Growth (YoY)

6974.00%

How profitable and efficient is PFE's business model?

Pfizer Inc achieves a profit margin of 16.80%, meaning it retains $16.80 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 28.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 12.20% and ROA at 5.25%, the company achieves moderate returns on invested capital.

What are PFE's recent growth trends?

Pfizer Inc's revenue grew by 10.30% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 6974.00% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against PHARMACEUTICAL PREPARATIONS industry averages for proper context.

Dividend Information

Dividend Per Share

$1.70

Dividend Yield

6.91%

Ex-Dividend Date

7/25/2025

Dividend Date

9/2/2025

What dividend income can investors expect from PFE?

Pfizer Inc offers a dividend yield of 6.91%, paying $1.70 per share annually. This high yield exceeds 4%, significantly outperforming the S&P 500 average of 1.5-2% and most investment-grade bonds. For income-focused investors, this represents an attractive cash flow opportunity, though high yields sometimes signal market concerns about sustainability. To receive the next dividend, shares must be purchased before the ex-dividend date of 7/25/2025.

How reliable is PFE's dividend for long-term investors?

The dividend sustainability can be assessed through the payout ratio - Pfizer Inc pays $1.70 per share in dividends against earnings of $1.89 per share, resulting in a payout ratio of 89.95%. This high payout ratio of 60-90% leaves limited earnings for reinvestment. While currently sustainable, there's less buffer for dividend growth or protection during earnings downturns. The next dividend payment is scheduled for 9/2/2025.

Company Size & Market

Shares Outstanding

5.69B

Book Value/Share

$15.60

Asset Type

Common Stock

What is PFE's market capitalization and position?

Pfizer Inc has a market capitalization of $140.77B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 5.69B shares outstanding, the company's ownership is widely distributed. As a major player in the PHARMACEUTICAL PREPARATIONS industry, it competes with other firms in this sector.

How does PFE's price compare to its book value?

Pfizer Inc's book value per share is $15.60, while the current stock price is $24.88, resulting in a price-to-book (P/B) ratio of 1.59. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$28.77

15.64% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

How reliable are analyst predictions for PFE?

24 analysts cover PFE with 33% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $28.77 implies 15.6% upside, but targets are often adjusted to follow price moves rather than predict them.

What is the Wall Street consensus on PFE?

Current analyst recommendations:1 Strong Buy, 7 Buy, 15 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 1, 2025, 06:04 AM

Condition	Threshold	Created At
Price rises above	$29.00	Sep 6, 2025, 08:46 AM

Condition

Threshold

Created At

Price rises above

$29.00

Sep 6, 2025, 08:46 AM

Pfizer Inc (PFE) Stock